To investigate the efficacy of Alphataxin to elevate CD4+ T cell numbers under differing conditions, orthotopic studies were conducted using varying numbers of implanted adenocarcinoma cells, Alphataxin doses, and time of initiation of treatment. This evidence concerns the gene CD4 and adenocarcinoma.